These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33288658)

  • 1. Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry.
    Sapkota Y; Qin N; Ehrhardt MJ; Wang Z; Chen Y; Wilson CL; Estepp J; Rai P; Hankins JS; Burridge PW; Jefferies JL; Zhang J; Hudson MM; Robison LL; Armstrong GT; Mulrooney DA; Yasui Y
    Cancer Res; 2021 May; 81(9):2556-2565. PubMed ID: 33288658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Locus on 6p21.2 for Cancer Treatment-Induced Cardiac Dysfunction Among Childhood Cancer Survivors.
    Sapkota Y; Ehrhardt MJ; Qin N; Wang Z; Liu Q; Qiu W; Shelton K; Shao Y; Plyler E; Mulder HL; Easton J; Michael JR; Burridge PW; Wang X; Wilson CL; Jefferies JL; Chow EJ; Oeffinger KC; Morton LM; Li C; Yang JJ; Zhang J; Bhatia S; Mulrooney DA; Hudson MM; Robison LL; Armstrong GT; Yasui Y
    J Natl Cancer Inst; 2022 Aug; 114(8):1109-1116. PubMed ID: 35698272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy.
    Ehrhardt MJ; Liu Q; Mulrooney DA; Rhea IB; Dixon SB; Lucas JT; Sapkota Y; Shelton K; Ness KK; Srivastava DK; McDonald A; Robison LL; Hudson MM; Yasui Y; Armstrong GT
    J Clin Oncol; 2024 Apr; 42(11):1265-1277. PubMed ID: 38207238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
    Feijen EAM; Leisenring WM; Stratton KL; Ness KK; van der Pal HJH; van Dalen EC; Armstrong GT; Aune GJ; Green DM; Hudson MM; Loonen J; Oeffinger KC; Robison LL; Yasui Y; Kremer LCM; Chow EJ
    JAMA Oncol; 2019 Jun; 5(6):864-871. PubMed ID: 30703192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
    Hines MR; Mulrooney DA; Hudson MM; Ness KK; Green DM; Howard SC; Krasin M; Metzger ML
    J Cancer Surviv; 2016 Feb; 10(1):113-21. PubMed ID: 26044903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Genome Sequencing of Childhood Cancer Survivors Treated with Cranial Radiation Therapy Identifies 5p15.33 Locus for Stroke: A Report from the St. Jude Lifetime Cohort Study.
    Sapkota Y; Cheung YT; Moon W; Shelton K; Wilson CL; Wang Z; Mulrooney DA; Zhang J; Armstrong GT; Hudson MM; Robison LL; Krull KR; Yasui Y
    Clin Cancer Res; 2019 Nov; 25(22):6700-6708. PubMed ID: 31462438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.
    Singh P; Shah DA; Jouni M; Cejas RB; Crossman DK; Magdy T; Qiu S; Wang X; Zhou L; Sharafeldin N; Hageman L; McKenna DE; Armenian SH; Balis FM; Hawkins DS; Keller FG; Hudson MM; Neglia JP; Ritchey AK; Ginsberg JP; Landier W; Bhatia R; Burridge PW; Bhatia S
    J Am Heart Assoc; 2023 Oct; 12(19):e029954. PubMed ID: 37750583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
    Wang X; Sun CL; Quiñones-Lombraña A; Singh P; Landier W; Hageman L; Mather M; Rotter JI; Taylor KD; Chen YD; Armenian SH; Winick N; Ginsberg JP; Neglia JP; Oeffinger KC; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Bhatia S
    J Clin Oncol; 2016 Mar; 34(8):863-70. PubMed ID: 26811534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association Study Identifies
    Wang X; Singh P; Zhou L; Sharafeldin N; Landier W; Hageman L; Burridge P; Yasui Y; Sapkota Y; Blanco JG; Oeffinger KC; Hudson MM; Chow EJ; Armenian SH; Neglia JP; Ritchey AK; Hawkins DS; Ginsberg JP; Robison LL; Armstrong GT; Bhatia S
    J Clin Oncol; 2023 Mar; 41(9):1758-1769. PubMed ID: 36508697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
    Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Relling MV; Burridge P; Bhatia S
    Cancer; 2020 Sep; 126(17):4051-4058. PubMed ID: 32413235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.
    Leerink JM; Feijen EAM; Moerland PD; de Baat EC; Merkx R; van der Pal HJH; Tissing WJE; Louwerens M; van den Heuvel-Eibrink MM; Versluys AB; Asselbergs FW; Sammani A; Teske AJ; van Dalen EC; van der Heiden-van der Loo M; van Dulmen-den Broeder E; de Vries ACH; Kapusta L; Loonen J; Pinto YM; Kremer LCM; Mavinkurve-Groothuis AMC; Kok WEM
    J Am Heart Assoc; 2022 Jul; 11(14):e025935. PubMed ID: 35861824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
    van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer.
    Im C; Neupane A; Baedke JL; Lenny B; Delaney A; Dixon SB; Chow EJ; Mostoufi-Moab S; Yang T; Richard MA; Gramatges MM; Lupo PJ; Sharafeldin N; Bhatia S; Armstrong GT; Hudson MM; Ness KK; Robison LL; Yasui Y; Wilson CL; Sapkota Y
    J Clin Oncol; 2024 Jul; 42(19):2306-2316. PubMed ID: 38652878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
    Armenian SH; Hudson MM; Mulder RL; Chen MH; Constine LS; Dwyer M; Nathan PC; Tissing WJ; Shankar S; Sieswerda E; Skinner R; Steinberger J; van Dalen EC; van der Pal H; Wallace WH; Levitt G; Kremer LC;
    Lancet Oncol; 2015 Mar; 16(3):e123-36. PubMed ID: 25752563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.
    Wang X; Liu W; Sun CL; Armenian SH; Hakonarson H; Hageman L; Ding Y; Landier W; Blanco JG; Chen L; Quiñones A; Ferguson D; Winick N; Ginsberg JP; Keller F; Neglia JP; Desai S; Sklar CA; Castellino SM; Cherrick I; Dreyer ZE; Hudson MM; Robison LL; Yasui Y; Relling MV; Bhatia S
    J Clin Oncol; 2014 Mar; 32(7):647-53. PubMed ID: 24470002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise recommendations for childhood cancer survivors exposed to cardiotoxic therapies: an institutional clinical practice initiative.
    Okada M; Meeske KA; Menteer J; Freyer DR
    J Pediatr Oncol Nurs; 2012; 29(5):246-52. PubMed ID: 22907680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.
    Ylänen K; Poutanen T; Savukoski T; Eerola A; Vettenranta K
    Acta Paediatr; 2015 Mar; 104(3):313-9. PubMed ID: 25393922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.